Welcome to LookChem.com Sign In|Join Free
  • or

Encyclopedia

Aminoguanidine

Base Information Edit
  • Chemical Name:Aminoguanidine
  • CAS No.:79-17-4
  • Molecular Formula:CH6 N4
  • Molecular Weight:74.0854
  • Hs Code.:
  • European Community (EC) Number:201-183-1
  • UNII:SCQ4EZQ113
  • DSSTox Substance ID:DTXSID5040964
  • Nikkaji Number:J5.508E
  • Wikipedia:Pimagedine
  • Wikidata:Q409583
  • NCI Thesaurus Code:C84059
  • Pharos Ligand ID:YSTM93VUK59G
  • Metabolomics Workbench ID:52257
  • ChEMBL ID:CHEMBL225304
  • Mol file:79-17-4.mol
Aminoguanidine

Synonyms:aminoguanidine;aminoguanidine sulfate;hydrazinecarboximidamide;monoaminoguanidine;pimagedine;pimagedine hydrochloride

Suppliers and Price of Aminoguanidine
Supply Marketing:Edit
Business phase:
The product has achieved commercial mass production*data from LookChem market partment
Manufacturers and distributors:
  • Manufacture/Brand
  • Chemicals and raw materials
  • Packaging
  • price
  • TRC
  • Pimagedinehydrochloride
  • 10mg
  • $ 45.00
  • Medical Isotopes, Inc.
  • Pimagedine 98%
  • 5 mg
  • $ 950.00
  • American Custom Chemicals Corporation
  • AMINOGUANIDINE 95.00%
  • 25G
  • $ 1146.05
Total 62 raw suppliers
Chemical Property of Aminoguanidine Edit
Chemical Property:
  • Vapor Pressure:0.0116mmHg at 25°C 
  • Melting Point:182-185 °C (decomp) 
  • Refractive Index:1.6660 (estimate) 
  • Boiling Point:261.4oC at 760 mmHg 
  • PKA:11.08±0.70(Predicted) 
  • Flash Point:111.9oC 
  • PSA:87.92000 
  • Density:1.72g/cm3 
  • LogP:0.23440 
  • XLogP3:-1.5
  • Hydrogen Bond Donor Count:3
  • Hydrogen Bond Acceptor Count:2
  • Rotatable Bond Count:0
  • Exact Mass:74.059246208
  • Heavy Atom Count:5
  • Complexity:41.6
Purity/Quality:

98%,99%, *data from raw suppliers

Pimagedinehydrochloride *data from reagent suppliers

Safty Information:
  • Pictogram(s):  
  • Hazard Codes: 
MSDS Files:

SDS file from LookChem

Useful:
  • Canonical SMILES:C(=NN)(N)N
  • Recent ClinicalTrials:A Clinical Trial to Evaluate the Safety and Efficacy of 'AG1904' in Acute Bronchitis
  • General Description Pimagedine (aminoguanidine) is a known inhibitor of advanced glycation endproduct (AGE) formation, functioning as a methylglyoxal (MG) scavenger to prevent non-enzymatic protein glycation associated with age-related diseases like diabetes. It has been compared to other AGE inhibitors, such as pyridoxamine and metformin, in studies evaluating therapeutic strategies for glycation-related complications. Its efficacy in inhibiting AGE formation highlights its potential as a therapeutic agent for conditions linked to excessive glycation.
Technology Process of Aminoguanidine

There total 38 articles about Aminoguanidine which guide to synthetic route it. The literature collected by LookChem mainly comes from the sharing of users and the free literature resources found by Internet computing technology. We keep the original model of the professional version of literature to make it easier and faster for users to retrieve and use. At the same time, we analyze and calculate the most feasible synthesis route with the highest yield for your reference as below:

synthetic route:
Refernces Edit

Synthesis of pyrazolo[1,5-c]pyrimidines from difluoroboron chelates of aroylacetones

10.1007/s11172-007-0154-5

The research presents a convenient method for synthesizing derivatives of 6H-pyrazolo[1,5-c]pyrimidine-7-thione and 7-aminopyrazolo[1,5-c]pyrimidine from difluoroboron chelate complexes of aroylacetones, amide acetals, and thiosemicarbazide or aminoguanidine. The study builds on previous work involving the synthesis of 5-aroylmethylpyrazoles and their hydrazones from difluoroboron chelate complexes of aroylacetones, amide acetals, and hydrazines. The key chemicals involved in this research include aroylacetones, difluoroboron chelates, amide acetals, thiosemicarbazide, and aminoguanidine. The reactions involve the formation of intermediate chelate complexes, which then undergo cyclization to produce the desired pyrazolo[1,5-c]pyrimidine derivatives. The synthesized compounds are characterized by various spectroscopic techniques, including 1H NMR, 13C NMR, 11B NMR, IR, and mass spectrometry. The study highlights the regioselectivity of the reactions and the potential biological activities of the synthesized pyrazolo[1,5-c]pyrimidines.

N-Terminal 2,3-diaminopropionic acid (Dap) peptides as efficient methylglyoxal scavengers to inhibit advanced glycation endproduct (AGE) formation

10.1016/j.bmc.2009.02.018

The research focuses on the development and evaluation of N-Terminal 2,3-diaminopropionic acid (Dap) peptides as efficient methylglyoxal (MG) scavengers to inhibit advanced glycation endproduct (AGE) formation. The purpose of this study was to address the issue of non-enzymatic glycation of proteins, which leads to the formation of AGEs that are associated with various age-related diseases and complications, including diabetes. The researchers synthesized N-terminal Dap peptides and assessed their ability to prevent protein modifications by MG, a highly reactive α-dicarbonyl compound. The peptides demonstrated a high scavenging potency, as evaluated through various assays including RP-HPLC, SDS–PAGE, and cell viability studies, and were compared to known AGE inhibitors such as aminoguanidine, pyridoxamine, metformin, and carnosine. The study concluded that N-terminal Dap containing dipeptides effectively inhibit the formation of AGEs and may provide a therapeutic potential for decelerating and treating AGE-related diseases. Chemicals used in the process included Dap and various amino acids to synthesize the peptides, as well as MG and other α-dicarbonyl compounds for the assessment of scavenging activity.

Post RFQ for Price